Online citations, reference lists, and bibliographies.

Aromatase Inhibitors (letrozole) For Subfertile Women With Polycystic Ovary Syndrome.

S. Franik, S. Eltrop, J. Kremer, L. Kiesel, C. Farquhar
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Polycystic ovary syndrome (PCOS) is the most common cause of infrequent periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 4% to 8% of women worldwide and often leads to anovulatory subfertility. Aromatase inhibitors (AIs) are a class of drugs that were introduced for ovulation induction in 2001. Since about 2001 clinical trials have reached differing conclusions as to whether the AI letrozole is at least as effective as the first-line treatment clomiphene citrate (CC). OBJECTIVES To evaluate the effectiveness and safety of aromatase inhibitors for subfertile women with anovulatory PCOS for ovulation induction followed by timed intercourse or intrauterine insemination (IUI). SEARCH METHODS We searched the following sources from inception to November 2017 to identify relevant randomised controlled trials (RCTs): the Cochrane Gynaecology and Fertility Group Specialised Register, the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO, Pubmed, LILACS, Web of Knowledge, the World Health Organization (WHO) clinical trials register and Clinicaltrials.gov. We also searched the references of relevant articles. We did not restrict the searches by language or publication status. SELECTION CRITERIA We included all RCTs of AIs used alone or with other medical therapies for ovulation induction in women of reproductive age with anovulatory PCOS. DATA COLLECTION AND ANALYSIS Two review authors independently selected trials, extracted the data and assessed risks of bias. We pooled studies where appropriate using a fixed-effect model to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for most outcomes, and risk differences (RDs) for ovarian hyperstimulation syndrome (OHSS). The primary outcomes were live birth and OHSS. Secondary outcomes were clinical pregnancy, miscarriage and multiple pregnancy. We assessed the quality of the evidence for each comparison using GRADE methods. MAIN RESULTS This is a substantive update of a previous review. We identified 16 additional studies for the 2018 update. We include 42 RCTs (7935 women). The aromatase inhibitor letrozole was used in all studies.Letrozole compared to clomiphene citrate (CC) with or without adjuncts followed by timed intercourseLive birth rates were higher with letrozole (with or without adjuncts) compared to clomiphene citrate (with our without adjuncts) followed by timed intercourse (OR 1.68, 95% CI 1.42 to 1.99; 2954 participants; 13 studies; I2 = 0%; number needed to treat for an additional beneficial outcome (NNTB) = 10; moderate-quality evidence). There is high-quality evidence that OHSS rates are similar with letrozole or clomiphene citrate (0.5% in both arms: risk difference (RD) -0.00, 95% CI -0.01 to 0.00; 2536 participants; 12 studies; I2 = 0%; high-quality evidence). There is evidence for a higher pregnancy rate in favour of letrozole (OR 1.56, 95% CI 1.37 to 1.78; 4629 participants; 25 studies; I2 = 1%; NNTB = 10; moderate-quality evidence). There is little or no difference between treatment groups in the rate of miscarriage by pregnancy (20% with CC versus 19% with letrozole; OR 0.94, 95% CI 0.70 to 1.26; 1210 participants; 18 studies; I2 = 0%; high-quality evidence) and multiple pregnancy rate (1.7% with CC versus 1.3% with letrozole; OR 0.69, 95% CI 0.41 to 1.16; 3579 participants; 17 studies; I2 = 0%; high-quality evidence). However, a funnel plot showed mild asymmetry, indicating that some studies in favour of clomiphene might be missing.Letrozole compared to laparoscopic ovarian drillingThere is low-quality evidence that live birth rates are similar with letrozole or laparoscopic ovarian drilling (OR 1.38, 95% CI 0.95 to 2.02; 548 participants; 3 studies; I2 = 23%; low-quality evidence). There is insufficient evidence for a difference in OHSS rates (RD 0.00, 95% CI -0.01 to 0.01; 260 participants; 1 study; low-quality evidence). There is low-quality evidence that pregnancy rates are similar (OR 1.28, 95% CI 0.94 to 1.74; 774 participants; 5 studies; I2 = 0%; moderate-quality evidence). There is insufficient evidence for a difference in miscarriage rate by pregnancy (OR 0.66, 95% CI 0.30 to 1.43; 240 participants; 5 studies; I2 = 0%; moderate-quality evidence), or multiple pregnancies (OR 3.00, 95% CI 0.12 to 74.90; 548 participants; 3 studies; I2 = 0%; low-quality evidence).Additional comparisons were made for Letrozole versus placebo, Selective oestrogen receptor modulators (SERMS) followed by intrauterine insemination (IUI), follicle stimulating hormone (FSH), Anastrozole, as well as dosage and administration protocols. There is insufficient evidence for a difference in either group of treatment due to a limited number of studies. Hence more research is necessary. AUTHORS' CONCLUSIONS Letrozole appears to improve live birth and pregnancy rates in subfertile women with anovulatory polycystic ovary syndrome, compared to clomiphene citrate. There is high-quality evidence that OHSS rates are similar with letrozole or clomiphene citrate. There is high-quality evidence of no difference in miscarriage rates or multiple pregnancy rates. There is low-quality evidence of no difference in live birth and pregnancy rates between letrozole and laparoscopic ovarian drilling, although there were few relevant studies. For the 2018 update, we added good-quality trials, upgrading the quality of the evidence.
This paper references
10.1016/j.fertnstert.2016.05.022
Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.
Xiao-ke Wu (2016)
[Effect of two different doses of letrozole in promoting ovulation in infertile women with polycystic ovarian syndrome].
M. Yang (2008)
10.1007/s00404-008-0888-9
Endometrial and follicular development following letrozole intervention in unexplained infertile patients failed to get pregnant with clomiphene citrate
Fatemeh Gatreh Samani (2008)
10.1210/JC.2006-0178
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
R. Azziz (2006)
Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome.
L. Nahid (2012)
10.1007/s00404-012-2579-9
Is letrozole superior to clomiphene for ovarian stimulation prior to intrauterine insemination?
S. Khanna (2012)
10.4038/cmj.v60i2.8152
A comparison of endometrial thickness following augmentation of ovulation with clomifene citrate or letrozole in women with ovulatory infertility.
Thilina Sanjeewa Palihawadana (2015)
Outcome of metformin treatment in polycystic ovary syndrome.
S A Anwary (2012)
10.4103/0976-9668.136241
A randomized trial comparing the ovulation induction efficacy of clomiphene citrate and letrozole
Mary Angel (2014)
10.1002/14651858.CD002249.pub5
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.
J. Brown (2016)
Comparing of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles
S. Akbari (2012)
10.1016/S0029-7844(97)00296-2
Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
E. M. (1997)
10.1016/j.fertnstert.2007.08.044
Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.
M. Begum (2009)
10.1016/j.fertnstert.2009.07.985
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.
Hatem Abu Hashim (2010)
10.2147/DDDT.S83259
Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study
Wenyan Xi (2015)
10.3349/ymj.2015.56.2.490
Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine Insemination
Bo Hyon Yun (2015)
10.4137/CMRH.S6598
Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination
Sherif F. Hendawy (2011)
10.1016/J.MEFS.2016.12.003
Use of clomiphene or letrozole for treating women with polycystic ovary syndrome related subfertility in Hilla city
Suhaila Fadhil Al-Shaikh (2017)
10.1007/s00404-010-1566-2
Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial
Hatem Abu Hashim (2010)
10.1007/s00404-013-2714-2
Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome
Ibrahim Abd Elgafor (2013)
10.1007/s00404-013-2780-5
Letrozole usage adjuvant to gonadotropins for ovulation induction for patients with clomiphene citrate failure
Ulku Ozdemir (2013)
10.1080/09513590.2017.1332174
Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial
Chang Liu (2017)
10.1021/jm00173a001
Mechanism and inhibition of cytochrome P-450 aromatase.
P. Cole (1990)
10.1016/S0015-0282(00)01705-2
Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate.
M. F. Mitwally (2001)
Pregnancies following the use of sequential treatment of metformin and incremental doses of letrozole in clomiphen-resistant women with polycystic ovary syndrome
Azam Azargoon (2012)
10.1089/GYN.2012.0033
Letrozole and Clomiphene Citrate Effect on Endometrial and Subendometrial Vascularity in Treating Infertility in Women with Polycystic Ovary Syndrome
Mohamed Fouad Selim (2012)
Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI
R. Davar (2011)
10.1016/S1701-2163(16)32551-8
Fetal safety of letrozole and clomiphene citrate for ovulation induction.
R. Forman (2007)
10.1016/J.MEFS.2017.02.003
Letrozole versus laparoscopic ovarian drilling in infertile women with PCOS resistant to clomiphene citrate
Mahmoud Haroun Ibrahim (2017)
10.1016/j.ijgo.2010.11.026
Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene‐resistant polycystic ovary syndrome
Mohamad S. Abdellah (2011)
10.1210/jcem.81.11.8923819
Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.
D. White (1996)
10.1016/S0015-0282(02)03225-9
A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome.
C. Farquhar (2002)
10.4103/2277-9175.174955
Gabapentin induces edema, hyperesthesia and scaling in a depressed patient; a diagnostic challenge
R. Bidaki (2016)
10.1111/j.1365-2265.2011.04006.x
Aromatase inhibitors for ovulation induction and ovarian stimulation
V. C. Lee (2011)
10.1097/GRF.0b013e3182353d0f
Use of the Aromatase Inhibitor Letrozole for Ovulation Induction in Women With Polycystic Ovarian Syndrome
Robert Casper (2011)
10.4103/0974-1208.97789
A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome
K. Roy (2012)
10.1016/j.fertnstert.2007.08.034
Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovary syndrome? A prospective controlled trial.
A. Badawy (2009)
10.1093/HUMREP/DEL020
Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.
F. Sohrabvand (2006)
Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome.
M. Zeinalzadeh (2010)
10.1093/humrep/der141
Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins.
M. Nahuis (2011)
10.1016/J.MEFS.2010.11.004
Predictors and characteristics of letrozole induced ovulation in comparison with clomiphene induced ovulation in anovulatory PCOS women
Mervat Sheikh-El-Arab Elsedeek (2011)
10.1016/j.ijgo.2015.06.063
A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene‐citrate‐resistant polycystic ovary syndrome
Waleed El-Khayat (2016)
10.3892/etm.2015.2690
Randomized controlled trial comparing letrozole with laparoscopic ovarian drilling in women with clomiphene citrate-resistant polycystic ovary syndrome
Wei Liu (2015)
10.1007/s00404-008-0714-4
Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler
J. Baruah (2008)
10.22074/IJFS.2015.4204
A Randomized Clinical Trial on Comparing The Cycle Characteristics of Two Different Initiation Days of Letrozole Treatment in Clomiphene Citrate Resistant PCOS Patients in IUI Cycles
Nayereh Ghomian (2015)
COMPARING THE EFFECTS OF CLOMIPHENE-HMG AND LETROZOLE-HMG ON OVULATION INDUCTION IN INFERTILE WOMEN
S. Ghazizadeh (2009)
10.1016/j.fertnstert.2010.06.008
Aromatase inhibitors in women with clomiphene citrate resistance: a randomized, double-blind, placebo-controlled trial.
M. Kamath (2010)
10.1093/humupd/dms003
Aromatase inhibitors for PCOS: a systematic review and meta-analysis.
M. Misso (2012)
10.5539/gjhs.v8n4p244
Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial
Azra Azmoodeh (2015)
10.1007/s00404-011-2091-7
Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome
Payal Banerjee Ray (2011)
10.1016/J.FERTNSTERT.2007.05.010
Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.
A. Badawy (2008)
10.1016/J.FERTNSTERT.2014.07.803
Luteal phase supplementation with vaginal progesterone in women with polycystic ovary syndrome and ovulatory dysfunction undergoing ovulation induction with letrozole: a randomized controlled trial
T. Pakrashi (2014)
Comparison of the Effects of Letrozole and Clomiphene Citrate on Ovulation and Pregnancy Rate in Patients with Polycystic Ovary Syndrome
S. Dehbashi (2009)
10.1093/HUMUPD/DMH044
Historical perspectives in gonadotrophin therapy.
B. Lunenfeld (2004)
10.1016/J.FERTNSTERT.2007.02.062
Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial.
A. Badawy (2009)
10.1056/NEJMoa1313517
Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.
R. Legro (2014)
10.1002/14651858.CD001122.pub4
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.
C. Farquhar (2012)
10.1177/147323000603400109
Comparison of Letrozole and Clomiphene Citrate in Women with Polycystic Ovaries Undergoing Ovarian Stimulation
V. Atay (2006)
10.1016/J.FERTNSTERT.2005.07.230
The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins
M. Biljan (2005)
10.1016/J.FERTNSTERT.2006.03.014
Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate.
T. Tulandi (2006)
10.1016/J.FERTNSTERT.2006.04.026
Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial.
U. Bayar (2006)
10.1136/bmjopen-2015-010955
Comparison of acupuncture pretreatment followed by letrozole versus letrozole alone on live birth in anovulatory infertile women with polycystic ovary syndrome: a study protocol for a randomised controlled trial
J. Li (2016)
10.1016/j.ijgo.2003.11.010
Comparison of two aromatase inhibitors in women with clomiphene‐resistant polycystic ovary syndrome
W. R. Al-Omari (2004)
10.1080/14647273.2016.1242783
Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial
A. Hassan (2017)
10.1016/j.fertnstert.2008.04.065
Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol.
A. Badawy (2009)
10.1007/s00404-011-1951-5
A randomized trial of ovulation induction with two different doses of Letrozole in women with PCOS
Fatemeh Ramezanzadeh (2011)
10.1093/humrep/der401
Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study.
R. Homburg (2012)
10.1210/JC.2005-1923
Aromatase inhibitors in ovulation induction.
M. F. Mitwally (2004)
10.29252/IJRM.15.1.49
Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A prospective randomized trial
Leila Pourali (2017)
10.5530/ami.2016.2.19
The effect of clomiphene citrate versus tamoxifen versus letrozol on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries
Asem Anwar (2016)
10.4103/0974-1208.106338
Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: A prospective randomized trial
S. Kar (2012)
10.1016/j.fertnstert.2008.10.009
Comparison of endocrine and ultrasound profiles during ovulation induction with clomiphene citrate and letrozole in ovulatory volunteer women.
P. Jirge (2010)
10.1007/s10815-008-9284-4
Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial
A. Ganesh (2008)
10.1007/s00404-012-2261-2
Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach
H. Hashim (2012)
Comparison of Letrozole Versus Tamoxifen Effects in Clomiphen Citrate Resistant Women with Polycystic Ovarian Syndrome
M. Elgharib (2015)
10.3109/09513590.2015.1096337
Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis
M. Roque (2015)
10.1093/humrep/dex227
Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome
S Amer (2017)
10.1016/j.fertnstert.2008.06.035
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
R. Azziz (2009)



This paper is referenced by
10.11603/bmbr.2706-6290.2019.2.10607
СИНДРОМ ПОЛІКІСТОЗНИХ ЯЄЧНИКІВ ЯК ЧИННИК ЕНДОКРИННОГО БЕЗПЛІДДЯ
M. S. Khmil (2020)
10.1186/s12958-019-0461-3
Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
Qiong Yu (2019)
10.1016/j.coemr.2020.03.003
Treatment update for anovulation and subfertility in polycystic ovary syndrome
Mariano Mascarenhas (2020)
10.1002/14651858.cd001122.pub5
Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome.
E M Bordewijk (2020)
10.1007/978-3-030-03594-5_3-1
The Polycystic Ovary Syndrome (PCOS)
Yvonne V. Louwers (2020)
10.1007/978-3-030-14782-2
Female Reproductive Dysfunction
Andrea Lenzi (2020)
10.1016/j.advms.2019.12.008
Proven and unproven methods for diagnosis and treatment of infertility.
Marian Szamatowicz (2020)
Polycystic Ovary Syndrome (PCOS): Current and Future Therapy
MN Maged (2020)
10.1055/s-0038-1668085
A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines.
A. C. H. Neven (2018)
10.18203/2320-1770.ijrcog20194362
Clomiphene citrate plus N-acetyl cysteine versus letrozole for induction of ovulation in infertile patients with polycystic ovarian disease: a randomized clinical trial
Mostafa Kamel (2019)
10.17513/spno.29466
USING OF AROMATASE INHIBITORS IN VITRO FERTILIZATION PROGRAMS
A. V. Lapshtaeva (2019)
10.1136/bmjopen-2019-035633
Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
K. Turner (2020)
10.1080/14740338.2019.1636964
Safety of fertility treatments in women with systemic autoimmune diseases (SADs)
Valeria Stella Vanni (2019)
10.1016/j.mce.2020.110760
Downregulation of Lnc-OC1 attenuates the pathogenesis of polycystic ovary syndrome
Gengxiang Wu (2020)
10.1093/humupd/dmz029
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Rui Wang (2019)
10.1111/ajo.13051
A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome
M. Costello (2019)
10.1002/14651858.CD010290.pub3
Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
N. S. Weiss (2019)
10.1210/jc.2019-00383
A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome.
Angela S Kelley (2019)
10.1002/CCA.2240
How does letrozole compare with other agents for subfertile women with polycystic ovary syndrome (PCOS)
Charalampos Siristatidis (2018)
10.1038/s41572-018-0058-8
Female subfertility
C. Farquhar (2019)
10.1097/MD.0000000000019045
Clinical effects of Shou-Wu Jiang-Qi Decoction combined acupuncture on the treatment of Polycystic Ovarian Syndrome with kidney deficiency, phlegm and blood stasisness
Wenting Xu (2020)
10.1007/978-3-030-03594-5_13-1
Hormonal Treatments in the Infertile Women
K. Dafopoulos (2020)
10.1097/MD.0000000000013038
Letrozole for patients with polycystic ovary syndrome
Hui-juan Guang (2018)
10.1007/s00404-019-05359-7
Basal Anti Mullerian hormone levels and endometrial thickness at midcycle can predict the outcome after clomiphene citrate stimulation in anovulatory women with PCOS, a retrospective study
A. Gaba (2019)
10.1177/1179558119849605
How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?
S L Jacob (2019)
10.12688/f1000research.15318.1
Recent advances in the understanding and management of polycystic ovary syndrome
A. L. Rocha (2019)
10.3390/medsci7090095
A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
M. Costello (2019)
10.1007/978-3-662-57636-6_15
Ovulationsinduktion und ovarielle Stimulation
Georg Griesinger (2020)
10.3390/medsci7070075
A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
M. Costello (2019)
10.1007/s43032-019-00072-x
Laparoscopic Ovarian Drilling Improves Endometrial Homeobox Gene Expression in PCOS
Senol Senturk (2020)
10.12816/AMJ.2020.67551
LETROZOLE VERSUS CLOMIPHENE CITRATE FOR OVULATION INDUCTION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Sameh Al-Shoraky Mohamed (2020)
10.1177/1179558119890867
Fertility Treatment Options for Women With Polycystic Ovary Syndrome
Shital Sawant (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar